News|Articles|May 15, 2020

Pharmaceutical Technology

  • Pharmaceutical Technology-05-15-2020
  • Volume 2020 eBook
  • Issue 2

Minimizing Contamination During Biopharma R&D

The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.

The right approach to biological safety cabinets (BSC), and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination. This article summarizes the key criteria for assessing BSC performance so that it prevents contamination.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing eBook.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 34–37

Citation

When referring to this article, please cite it as D. Phillips, "Minimizing Contamination During Biopharma R&D," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

 


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.